top of page
catalogue cover.jpg
logo blue.png
the thing.png

MesoGel BTX
Dermal Revitaliser & Fine Line Injectable

evolution.png

Clinical Indications & Target Areas

MesoGel BTX is indicated for intradermal micro-droplet injection to address early aging and superficial wrinkles:

  • Face: Softens dynamic forehead lines, crow’s feet, and perioral wrinkles.

  • Neck: Restores skin hydration and smooths surface crepiness.

  • Décolleté: Refines skin texture and reduces fine lines caused by sun exposure.

2% Non-Crosslinked Hyaluronic Acid (20 mg/mL) + Triple Neuromodulating Peptide Complex (GABA, Argireline®, Leuphasyl®)

MesoGel BTX (part of the Dermatological Choice MesoGel Collection) is an advanced 2-in-1 hybrid dermal gel formulated for bio-revitalisation and surface line softening. By integrating 20 mg/mL high-purity non-crosslinked Hyaluronic Acid (HA) with a targeted neuro-peptide complex, MesoGel BTX restores deep dermal hydration and reduces expression micro-tension in a single syringe.

74.png
73.png

Comparative Signal Modulation Analysis

Unlike traditional botulinum toxins or standard superficial serums, MesoGel BTX acts as a non-paralyzing bioactive gel.

table.jpg

Active Formulation & How It Works

  • 20 mg/mL Hyaluronic Acid Matrix: Provides deep hydration and structural dermal support.

  • Acetyl Hexapeptide-8 (Argireline®): Reduces acetylcholine release at the presynaptic junction to soften dynamic lines.

  • Pentapeptide-18 (Leuphasyl®): Lowers neuronal excitability in synergy with Argireline®.

  • Aminobutyric Acid (GABA): Fast-acting relaxation of surface micro-contractions.

All products and specifications are for EU market edition only.

Information provided may not apply to other regions. Pictures are not actual product

bottom of page